Breaking: Colorado Becomes the 2nd State to Decriminalize Psychedelics
PolicyIn a tight race that came down the wire, Colorado voters approve Measure 122 to decriminalize small amounts of psychedelic drugs
Drug Legalization Ballot Initiative Breakdown
PolicyPsychedelics and marijuana are on the ballot in six states this year, here's your guide to all the current drug legalization measures
Couple Sentenced to Eight Years for Czech Ayahuasca Ceremonies
Culture, PolicyA Polish couple is sentenced to eight years in prison for hosting ayahuasca ceremonies at their home in the Czech Republic
Alberta Becomes First Canadian Province to Approve Psychedelics for Therapy
PolicyIn a briefing on Wednesday, Alberta health officials said they are laying out a regulatory groundwork for anticipated psychedelic therapy
Psychedelic Decriminalization is on the Ballot in Colorado
PolicyThis November, Colorado voters have the chance to decriminalize psychedelic plant medicines for personal and therapeutic use
What’s in the San Francisco Psychedelics Decrim Resolution?
PolicySan Francisco becomes the latest city to decriminalize entheogenic plants in another win for Decriminalize Nature
An Inside Look at the Lawsuit that could “Legalize Psychedelics in Canada”
PolicyA lawsuit filed by the non-profit advocacy group TheraPsil is leading the effort to make psilocybin-assisted therapy available to Canadian patients with a doctor's recommendation
Breaking: DEA Backs Off, Won’t Criminalize Two New Psychedelics
PolicyThe DEA backs off announces they are withdrawing a proposed rule to ban the psychedelic drugs DOI and DOC, at least for now
Breaking: Canadian Minister Meets with the Oregon Psilocybin Advisory Board
PolicyThe Canadian Minister of Mental Health and Addictions met with members of the Oregon psilocybin program, a surprise move which may signify easing restrictions on psychedelics
The DEA is Attempting to Ban Two New Psychedelic Drugs
PolicyThe DEA moves to ban two obscure psychedelic drugs, DOI and DOC, amidst ongoing calls to ease restrictions on psychedelic medicines